Рет қаралды 7,461
ISB President Dr. Jim Heath and colleagues from UCLA and PACT Pharma talk about exciting new cancer research. A team of scientists have shown that immune system receptors can be isolated from a cancer patient’s blood and used to redirect immune cells to recognize cancer using CRISPR gene editing. The incredible findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.